Less than two months after the gigantic QuintilesIMS officially came into being, the newly merged company has snapped up the clinical trials division of TKL…

BenevolentAI's ambition to use artificial intelligence to revolutionize the drug development process is one step closer after a deal with Janssen.

Emas Pharma, a CRO that provides biopharma and medical device services, has been bought by outsourced specialist Bionica and joined the latter’s existing…

Induced pluripotent stem cell (iPSC) specialist Axiogenesis AG has partnered with ion channel CRO Metrion Biosciences to develop human iPSC-derived…

In its first quarter after the merger of Quintiles and IMS Health, the newly formed single company said it has kick-started a $1.5 billion repurchase of…

London-based trial services co Ergomed has penned a deal with Swedish biotech Asarina Pharma for its Phase IIb trial of sepranolone in patients with…

Premier Research has been given what the company is dubbing a “growth investment” from Metalmark Capital, a New York-based private equity firm--although…

Data and clinical ops contract research org FMD K&L has merged with similarly multifaceted CRO iMEDGlobal in what it believes will create both a…

WuXi AppTec enjoys building: Back at the start of 2016, it announced it was to erect a $120 million "biologics solution center" in Shanghai and as we…

Deals